A critical look at cefepime breakpoints in vivo an assessment of cefepime activity against carbapenemase-producing enterobacterales with unexpected cefepim -156.
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00128
- Awardee
-
Hartford Hospital UEI UJGNPDP2ETM3 Part of Hartford Healthcare Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $249,975
Award facts
- Opportunity
-
- FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2100123 · Posted Nov 20, 2020
- Contract value 100% obligated
- $249,975.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Hartford, CT 06102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $249,975 |
About this award
This federal contract award is a definitive contract between the Department of Health and Human Services' Food and Drug Administration (FDA) and Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, valued at $249,975.00, is for research and development activities related to assessing the activity of the antibiotic cefepime against carbapenemase-producing Enterobacterales. This contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which sought proposals across various areas of regulatory science to support the FDA's mission. The contract does not have a set-aside designation. As the prime contractor, Hartford Hospital will provide research services, including patient screening, recruitment, data collection, and communication support. This contract is part of the FDA's ongoing efforts to modernize toxicology, support clinical innovation, and strengthen regulatory science.
Quick answers
Who was awarded contract 75F40121C00128?
75F40121C00128 was awarded to Hartford Hospital by Food and Drug Administration (Department of Health and Human Services) on September 28, 2021.
How much is contract 75F40121C00128 worth?
The government has obligated $249,975 on 75F40121C00128.
Was contract 75F40121C00128 competed?
The extent of competition for 75F40121C00128 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award